Wood, Martyn D <br/><br/>
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.  [electronic resource] 

 -  European journal of pharmacology  Sep 2006 
 - 88-94 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2006.07.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amphetamine<br/>Animals<br/>Antipsychotic Agents--metabolism<br/>Aripiprazole<br/>Behavior, Animal--drug effects<br/>Binding, Competitive<br/>Biotransformation<br/>CHO Cells<br/>Catalepsy--chemically induced<br/>Cricetinae<br/>Cricetulus<br/>Dopamine D2 Receptor Antagonists<br/>Dyskinesia, Drug-Induced--etiology<br/>Guanosine 5'-O-(3-Thiotriphosphate)--metabolism<br/>HeLa Cells<br/>Humans<br/>Male<br/>Motor Activity--drug effects<br/>Oxidopamine<br/>Piperazines--metabolism<br/>Quinolones--metabolism<br/>Radioligand Assay<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D2--agonists<br/>Species Specificity<br/>Transfection